Β-Diketone-cobalt Complexes Inhibit DNA Synthesis and Induce S-phase Arrest in Rat C6 Glioma Cells.

Kaizhi Zhang,Xingli Zhao,Junzhi Liu,Xiangyang Fang,Xuepeng Wang,Xiaohong Wang,Rui Li
DOI: https://doi.org/10.3892/ol.2013.1772
2013-01-01
Oncology Letters
Abstract:β-diketone-cobalt complexes, a family of newly synthesized non-platinum metal compounds, exhibit potential antitumor activity; however, the antitumor mechanism is unclear. The current study investigated the mechanism by which β-diketone-cobalt complexes inhibit rat C6 glioma cell proliferation. It was found that β-diketone-cobalt complexes suppress rat C6 glioma cell viability in a dose-dependent manner (3.125-100 μg/ml). In rat C6 glioma cells, the IC50 value of β-diketone-cobalt complexes was 24.7±3.395 μg/ml and the IC10 value was 4.37±1.53 μg/ml, indicating a strong inhibitory effect. Further investigation suggested that β-diketone-cobalt complexes inhibit rat C6 glioma cell proliferation, which is associated with S-phase arrest and DNA synthesis inhibition. During this process, β-diketone-cobalt complexes decreased cyclin A expression and increased cyclin E and p21 expression. In addition, β-diketone-cobalt complexes exhibit a stronger antitumor capability than the antineoplastic agent, 5-fluorouracil.
What problem does this paper attempt to address?